News Related to Estrogen Receptor-Positive Breast Cancer

Related coverage linked through entity extraction aliases.

Breast Cancer Treatment Side Effects: Cardiotoxicity and Bone Health Challenges

Mar 13, 2026

Recent studies examine self-management strategies for breast cancer treatment-related cardiotoxicity and highlight risks of vertebral fractures after discontinuing denosumab therapy in patients receiving aromatase inhibitors.

FDA Accepts Giredestrant Application for ESR1-Mutated Advanced Breast Cancer

Mar 10, 2026

The FDA has accepted Roche's new drug application for giredestrant plus everolimus to treat ER-positive, HER2-negative, ESR1-mutated advanced breast cancer following prior endocrine therapy, with a decision expected by December 18, 2026.